Social Media

Sunday, August 4, 2019

Merck Reports Strong 2nd Quarter Sending Stock Near All Time High

(Rahway, NJ) Pharmaceutical giant Merck & Co reported strong 2nd Quarter financials this week sending the stock soaring near an all time and closing the week @ $84.81.  
Worldwide sales increased 15% to $11.8 billion.
$1.03 EPS for the 2nd Quarter 
Keytruda (cancer drug) sales generated $2.6 billion (+63%)
Fiscal Year 2019 Sales Outlook raised to $46.2 Billion
FDA Approves New Monotherapy Indication for KeyTruda
MERCK Up 64% in 14 months
Our last review of the common stock of Merck (NYSE: MRK) was in May 2018 after the company reported FY2018 1st quarter financials and shares were trading at $59.14 ($51.58 adjusted for dividend).  This week the stock closed @ $84.47 an increase of 64% in 14 months! Over the same 14 month period the Dow Jones Industrial Average as risen 7%. 

(Merck & Co. is a member of the Dow Jones Industrial Index and trades on the New York Stock exchange and is now headquartered in Kenilworth, NJ after it acquired Schering Plough.)


No comments:

Post a Comment